Evaluation of NMES Therapy for Pain Relief Associated With Knee Osteoarthritis

NCT04367597 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2021-03-18

No results posted yet for this study

Summary

A roll-over study of the current CM-2019 trial to assess the same preplanned outcomes of CM-2019 at 14 weeks.

Conditions

Interventions

DEVICE

Home-based Neuromuscular Electrical Stimulation (NMES) therapy

A home-based NMES treatment applied by the subjects daily

Sponsors & Collaborators

  • CyMedica Orthopedics, Inc

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-04-20
Primary Completion
2020-08-20
Completion
2021-03-16
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04367597 on ClinicalTrials.gov